STAT+: Oura’s acquisition of health tech startup raises conflict-of-interest questions for Eli Lilly, experts say
With a new deal announced this week, the relationship between Eli Lilly and a telehealth company that markets GLP-1s is expected to grow more complicated.
This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.
Read the full story at STAT ↗statnews.com
More from the Health desk
Just in
Woman with terminal cancer gets dream wedding on hospital ward
STAT+: Enforcement of stringent Medicaid work requirements delayed for six months
STAT+: Democrats coalesce around ‘Medicare for More,’ ‘Medikids’ proposals
